Review



salinomycin sodium sacox 200 microgranulate  (Huvepharma Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Huvepharma Inc salinomycin sodium sacox 200 microgranulate
    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to <t> salinomycin </t> total residues based on residue data in rabbit tissues.
    Salinomycin Sodium Sacox 200 Microgranulate, supplied by Huvepharma Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/salinomycin sodium sacox 200 microgranulate/product/Huvepharma Inc
    Average 90 stars, based on 1 article reviews
    salinomycin sodium sacox 200 microgranulate - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Safety and efficacy of a feed additive consisting of salinomycin sodium (Sacox®) for rabbits for fattening (Huvepharma N.V.)"

    Article Title: Safety and efficacy of a feed additive consisting of salinomycin sodium (Sacox®) for rabbits for fattening (Huvepharma N.V.)

    Journal: EFSA Journal

    doi: 10.2903/j.efsa.2024.8796

    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues based on residue data in rabbit tissues.
    Figure Legend Snippet: Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues based on residue data in rabbit tissues.

    Techniques Used: Residue

    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on MRLs.
    Figure Legend Snippet: Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on MRLs.

    Techniques Used:

    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on chicken and rabbit MRLs.
    Figure Legend Snippet: Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on chicken and rabbit MRLs.

    Techniques Used:



    Similar Products

    salinomycin sodium sacox 200 microgranulate  (Huvepharma Inc)
    90
    Huvepharma Inc salinomycin sodium sacox 200 microgranulate
    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to <t> salinomycin </t> total residues based on residue data in rabbit tissues.
    Salinomycin Sodium Sacox 200 Microgranulate, supplied by Huvepharma Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/salinomycin sodium sacox 200 microgranulate/product/Huvepharma Inc
    Average 90 stars, based on 1 article reviews
    salinomycin sodium sacox 200 microgranulate - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues based on residue data in rabbit tissues.

    Journal: EFSA Journal

    Article Title: Safety and efficacy of a feed additive consisting of salinomycin sodium (Sacox®) for rabbits for fattening (Huvepharma N.V.)

    doi: 10.2903/j.efsa.2024.8796

    Figure Lengend Snippet: Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues based on residue data in rabbit tissues.

    Article Snippet: Commission Implementing Regulation (EU) 2017/1914 of 19 October 2017 concerning the authorisation of salinomycin sodium (Sacox 120 microGranulate and Sacox 200 microGranulate) as a feed additive for chickens for fattening and chickens reared for laying and repealing Regulations (EC) No 1852/2003 and (EC) No 1463/2004 (holder of authorisation Huvepharma NV).

    Techniques: Residue

    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on MRLs.

    Journal: EFSA Journal

    Article Title: Safety and efficacy of a feed additive consisting of salinomycin sodium (Sacox®) for rabbits for fattening (Huvepharma N.V.)

    doi: 10.2903/j.efsa.2024.8796

    Figure Lengend Snippet: Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on MRLs.

    Article Snippet: Commission Implementing Regulation (EU) 2017/1914 of 19 October 2017 concerning the authorisation of salinomycin sodium (Sacox 120 microGranulate and Sacox 200 microGranulate) as a feed additive for chickens for fattening and chickens reared for laying and repealing Regulations (EC) No 1852/2003 and (EC) No 1463/2004 (holder of authorisation Huvepharma NV).

    Techniques:

    Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on chicken and rabbit MRLs.

    Journal: EFSA Journal

    Article Title: Safety and efficacy of a feed additive consisting of salinomycin sodium (Sacox®) for rabbits for fattening (Huvepharma N.V.)

    doi: 10.2903/j.efsa.2024.8796

    Figure Lengend Snippet: Chronic dietary exposure per population class, country and survey of consumers (mg/kg bw per day) to salinomycin total residues calculated based on chicken and rabbit MRLs.

    Article Snippet: Commission Implementing Regulation (EU) 2017/1914 of 19 October 2017 concerning the authorisation of salinomycin sodium (Sacox 120 microGranulate and Sacox 200 microGranulate) as a feed additive for chickens for fattening and chickens reared for laying and repealing Regulations (EC) No 1852/2003 and (EC) No 1463/2004 (holder of authorisation Huvepharma NV).

    Techniques: